Key Details
Price
$208.60Annual Revenue
$3.86 BAnnual EPS
$5.81Annual ROE
12.31%Beta
1.39Events Calendar
Next earnings date:
Feb 05, 2025Recent quarterly earnings:
Oct 23, 2024Recent annual earnings:
Jan 31, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
Align Technology's stock has struggled over the last year because of weak consumer interest in its clear aligner products. However, I anticipate that growth will pick up to at least 5% in FY25, largely due to high demand for the systems and services offered to doctors. Additionally, profit margins are likely to increase after the restructuring plan that started in Q4.
TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN), a top global medical device company known for its Invisalign® clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, has announced that it will share its financial results for the fourth quarter and 2024 on Wednesday, February 5, 2025, after the market closes. The results will be available at 4:00 p.m. ET (2:00 p.m. MT).
ALGN stock remains a focus for investors due to its promising Invisalign prospects and achievements with iTero.
SANTA CLARA, Calif.--(BUSINESS WIRE)--On Wednesday, lawyers from Susman Godfrey LLP and Benesch Friedlander Coplan & Aronoff, LLP submitted an antitrust lawsuit for CDS Litigation, LLC against Align Technology, Inc., the American Dental Association (ADA), and the American Association of Orthodontists (AAO). The lawsuit, which was filed in California's Superior Court, claims that the defendants participated in a long-term, illegal conspiracy to undermine competition.
ALGN is experiencing a drop in the average selling prices (ASPs) of Invisalign for complete treatment options. This decline is leading to a decrease in the company's overall revenue.
Investors should closely monitor Align Technology (ALGN) stock due to recent changes in the options market.
Align Technology (ALGN) shared its earnings report 30 days ago. What can we expect for the stock moving forward?
TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a top global medical device firm known for its Invisalign® clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, has announced its participation in several upcoming financial conferences. The presentations will be available for live streaming through the Investor Relations section.
Align Technology has introduced the Invisalign Smile Architect software, which offers various treatment plans for personalized care. This new tool aims to provide tailored treatment options for users.
Align Technology shared mixed results for their Q3 earnings, achieving an EPS of $2.35 but falling short on revenue at $977.87 million. Although they faced difficulties in the U.S. market, they experienced growth in Asia Pacific, EMEA, and Latin America, along with a rise in Clear Aligner sales. The company attributes its growth to product improvements, investments in infrastructure, and partnerships, forecasting a revenue increase of 5.29%-7.53% year-over-year from Q4 2024 to Q4 2026.
FAQ
- What is the primary business of Align Technology?
- What is the ticker symbol for Align Technology?
- Does Align Technology pay dividends?
- What sector is Align Technology in?
- What industry is Align Technology in?
- What country is Align Technology based in?
- When did Align Technology go public?
- Is Align Technology in the S&P 500?
- Is Align Technology in the NASDAQ 100?
- Is Align Technology in the Dow Jones?
- When was Align Technology's last earnings report?
- When does Align Technology report earnings?
- Should I buy Align Technology stock now?